vs

Side-by-side financial comparison of CABOT CORP (CBT) and ITRON, INC. (ITRI). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $587.0M, roughly 1.4× ITRON, INC.). ITRON, INC. runs the higher net margin — 9.1% vs 8.6%, a 0.5% gap on every dollar of revenue. On growth, ITRON, INC. posted the faster year-over-year revenue change (-3.3% vs -11.1%). ITRON, INC. produced more free cash flow last quarter ($79.0M vs $57.0M). Over the past eight quarters, ITRON, INC.'s revenue compounded faster (-1.8% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Itron, Inc. is an American technology company that offers products and services for energy and water resource management. It is headquartered in Liberty Lake, Washington, United States. The company's products measure and analyze electricity, gas and water consumption. Its products include electricity, gas, water and thermal energy measurement devices and control technology, communications systems, software, as well as managed and consulting services.

CBT vs ITRI — Head-to-Head

Bigger by revenue
CBT
CBT
1.4× larger
CBT
$849.0M
$587.0M
ITRI
Growing faster (revenue YoY)
ITRI
ITRI
+7.8% gap
ITRI
-3.3%
-11.1%
CBT
Higher net margin
ITRI
ITRI
0.5% more per $
ITRI
9.1%
8.6%
CBT
More free cash flow
ITRI
ITRI
$22.0M more FCF
ITRI
$79.0M
$57.0M
CBT
Faster 2-yr revenue CAGR
ITRI
ITRI
Annualised
ITRI
-1.8%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBT
CBT
ITRI
ITRI
Revenue
$849.0M
$587.0M
Net Profit
$73.0M
$53.6M
Gross Margin
24.9%
40.3%
Operating Margin
15.2%
11.5%
Net Margin
8.6%
9.1%
Revenue YoY
-11.1%
-3.3%
Net Profit YoY
-21.5%
-18.0%
EPS (diluted)
$1.37
$1.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
ITRI
ITRI
Q1 26
$587.0M
Q4 25
$849.0M
$571.7M
Q3 25
$899.0M
$581.6M
Q2 25
$923.0M
$606.8M
Q1 25
$936.0M
$607.2M
Q4 24
$955.0M
$612.9M
Q3 24
$1.0B
$615.5M
Q2 24
$1.0B
$609.1M
Net Profit
CBT
CBT
ITRI
ITRI
Q1 26
$53.6M
Q4 25
$73.0M
$101.6M
Q3 25
$43.0M
$65.6M
Q2 25
$101.0M
$68.3M
Q1 25
$94.0M
$65.5M
Q4 24
$93.0M
$58.1M
Q3 24
$137.0M
$78.0M
Q2 24
$109.0M
$51.3M
Gross Margin
CBT
CBT
ITRI
ITRI
Q1 26
40.3%
Q4 25
24.9%
40.5%
Q3 25
24.5%
37.7%
Q2 25
26.4%
36.9%
Q1 25
25.7%
35.8%
Q4 24
24.6%
34.9%
Q3 24
24.0%
34.1%
Q2 24
25.2%
34.6%
Operating Margin
CBT
CBT
ITRI
ITRI
Q1 26
11.5%
Q4 25
15.2%
13.8%
Q3 25
15.2%
14.1%
Q2 25
18.1%
12.6%
Q1 25
17.3%
12.6%
Q4 24
16.2%
10.2%
Q3 24
15.0%
12.0%
Q2 24
16.9%
10.6%
Net Margin
CBT
CBT
ITRI
ITRI
Q1 26
9.1%
Q4 25
8.6%
17.8%
Q3 25
4.8%
11.3%
Q2 25
10.9%
11.3%
Q1 25
10.0%
10.8%
Q4 24
9.7%
9.5%
Q3 24
13.7%
12.7%
Q2 24
10.7%
8.4%
EPS (diluted)
CBT
CBT
ITRI
ITRI
Q1 26
$1.18
Q4 25
$1.37
$2.20
Q3 25
$0.80
$1.41
Q2 25
$1.86
$1.47
Q1 25
$1.69
$1.42
Q4 24
$1.67
$1.26
Q3 24
$2.41
$1.70
Q2 24
$1.94
$1.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
ITRI
ITRI
Cash + ST InvestmentsLiquidity on hand
$230.0M
$712.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$1.6B
Total Assets
$3.8B
$4.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
ITRI
ITRI
Q1 26
$712.9M
Q4 25
$230.0M
$1.0B
Q3 25
$258.0M
$1.3B
Q2 25
$239.0M
$1.2B
Q1 25
$213.0M
$1.1B
Q4 24
$183.0M
$1.1B
Q3 24
$223.0M
$982.5M
Q2 24
$197.0M
$920.6M
Total Debt
CBT
CBT
ITRI
ITRI
Q1 26
Q4 25
$1.3B
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
$1.3B
Q3 24
$1.1B
$1.3B
Q2 24
$1.3B
Stockholders' Equity
CBT
CBT
ITRI
ITRI
Q1 26
$1.6B
Q4 25
$1.6B
$1.7B
Q3 25
$1.6B
$1.7B
Q2 25
$1.5B
$1.6B
Q1 25
$1.4B
$1.5B
Q4 24
$1.4B
$1.4B
Q3 24
$1.4B
$1.3B
Q2 24
$1.3B
$1.2B
Total Assets
CBT
CBT
ITRI
ITRI
Q1 26
$4.0B
Q4 25
$3.8B
$3.7B
Q3 25
$3.8B
$3.7B
Q2 25
$3.8B
$3.6B
Q1 25
$3.8B
$3.5B
Q4 24
$3.6B
$3.4B
Q3 24
$3.7B
$3.4B
Q2 24
$3.6B
$3.3B
Debt / Equity
CBT
CBT
ITRI
ITRI
Q1 26
Q4 25
0.74×
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
0.91×
Q3 24
0.75×
0.94×
Q2 24
1.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
ITRI
ITRI
Operating Cash FlowLast quarter
$126.0M
$85.5M
Free Cash FlowOCF − Capex
$57.0M
$79.0M
FCF MarginFCF / Revenue
6.7%
13.5%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
1.60×
TTM Free Cash FlowTrailing 4 quarters
$401.0M
$394.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
ITRI
ITRI
Q1 26
$85.5M
Q4 25
$126.0M
$119.3M
Q3 25
$219.0M
$117.8M
Q2 25
$249.0M
$96.7M
Q1 25
$73.0M
$72.1M
Q4 24
$124.0M
$79.8M
Q3 24
$204.0M
$65.3M
Q2 24
$207.0M
$51.7M
Free Cash Flow
CBT
CBT
ITRI
ITRI
Q1 26
$79.0M
Q4 25
$57.0M
$111.5M
Q3 25
$155.0M
$113.4M
Q2 25
$188.0M
$90.7M
Q1 25
$1.0M
$67.5M
Q4 24
$47.0M
$70.2M
Q3 24
$112.0M
$58.7M
Q2 24
$155.0M
$44.6M
FCF Margin
CBT
CBT
ITRI
ITRI
Q1 26
13.5%
Q4 25
6.7%
19.5%
Q3 25
17.2%
19.5%
Q2 25
20.4%
14.9%
Q1 25
0.1%
11.1%
Q4 24
4.9%
11.4%
Q3 24
11.2%
9.5%
Q2 24
15.3%
7.3%
Capex Intensity
CBT
CBT
ITRI
ITRI
Q1 26
Q4 25
8.1%
1.4%
Q3 25
7.1%
0.8%
Q2 25
6.6%
1.0%
Q1 25
7.7%
0.8%
Q4 24
8.1%
1.6%
Q3 24
9.2%
1.1%
Q2 24
5.1%
1.2%
Cash Conversion
CBT
CBT
ITRI
ITRI
Q1 26
1.60×
Q4 25
1.73×
1.17×
Q3 25
5.09×
1.80×
Q2 25
2.47×
1.41×
Q1 25
0.78×
1.10×
Q4 24
1.33×
1.37×
Q3 24
1.49×
0.84×
Q2 24
1.90×
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

ITRI
ITRI

Product revenues$477.8M81%
Service revenues$109.2M19%

Related Comparisons